Resources

1 Resources for

sanjay kaul

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

FDA's Prasugrel Machinations Seem Bound to Attract Doubt
UPDATE: Dr. Sanjay Kaul was bounced from the FDA's prasugrel panel after Eli Lilly called the FDA to question his inclusion on the panel, according to HeartWire. The FDA has admitted it made a "mistake" by axing Kaul. "At every step of the way there were errors by multiple parties,"...
Tags: FDA, Sanjay Kaul, Federal Government, Government, Jim Edwards
Blog posts 2009-02-23

Additional Resources

More Bad News for Lilly's Prasugrel
The bleeding risks of Eli Lilly's new blood thinner, prasugrel, are less clear than the company thinks, according to a Cedars Sinai cardiologist. The drug -- which Lilly hopes will be huge -- is currently under review by the FDA but has suffered a series of delays that have set...
Tags: FDA, Patient, Lilly, Federal Government, Government, Jim Edwards
Blog posts 2008-11-11
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement
Click Here